Durvalumab in Small-Cell Lung Cancer. Reply
- PMID: 39693557
- DOI: 10.1056/NEJMc2414036
Durvalumab in Small-Cell Lung Cancer. Reply
Comment on
-
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.N Engl J Med. 2024 Oct 10;391(14):1313-1327. doi: 10.1056/NEJMoa2404873. Epub 2024 Sep 13. N Engl J Med. 2024. PMID: 39268857 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources